Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Here is Why JPMorgan is Overweight on Apellis Pharma (APLS)
Apellis Pharmaceuticals Inc. (NASDAQ: APLS) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 5, Anupam Rama from JPMorgan increased the price target on Apellis Pharmaceuticals Inc. (NASDAQ:APLS) from $36 to…
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 2, Wedbush analyst Laura Chico increased the firm's price target on BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) to…
Zealand Pharma to participate in upcoming investor conferences in March 2026
Press release – No. 5 / 2026 Zealand Pharma to participate in upcoming investor conferences in March 2026 Copenhagen, Denmark, March 9, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming…
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 20, Bank of America Securities lowered the price target on Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) from $570…
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more
Check out some of the companies making the biggest midday moves: Oil stocks – Oil stocks briefly traded higher as the commodity surged as the Iran War showed no sign of abating. U.S. crude briefly topped $110 per barrel overnight, hitting…
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
Issued on behalf of Cybin D/B/A Helus Pharma VANCOUVER, BC, March 9, 2026 /CNW/ -- The central nervous system therapeutics sector is approaching a commercial inflection point as multiple candidates advance through late-stage trials and regulatory…
Nifty holds 24,200 at midday; Auto and Pharma lead gains as IT drags
Markets extended the morning's recovery into the afternoon session on Tuesday, with the benchmark indices trading higher around midday, building on the gap-up open triggered by easing geopolitical tensions and a sharp retreat in global crude oil…
BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at William Blair
Investment analysts at William Blair started coverage on shares of BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) in a research note issued to investors on Tuesday. The firm set an 'outperform' rating on the stock. BridgeBio's Volatile Week Puts…
Spyglass Pharma (NASDAQ:SGP) Coverage Initiated by Analysts at HC Wainwright
Investment analysts at HC Wainwright began coverage on shares of Spyglass Pharma (NASDAQ:SGP - Get Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The firm set a 'buy' rating and a $37.00 price target on the stock.
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $3,165,350.10 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 104,467 shares of NewAmsterdam Pharma stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $30.30…
Royalty Pharma PLC $RPRX Shares Purchased by Capital International Sarl
Capital International Sarl raised its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned…
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells 94,124 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 94,124 shares of the company's stock in a transaction on Friday, March 6th. The stock was sold at an average price of $30.32, for a total…
Victory Capital Management Inc. Purchases 141,800 Shares of BridgeBio Pharma, Inc. $BBIO
Victory Capital Management Inc. grew its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 42.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 479,680 shares of the company's…
Johannes Jacob Piete Kastelein Sells 101,409 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 101,409 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $30.29, for a…
Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Rating of 'Moderate Buy' from Brokerages
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the eighteen ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell…
Receive a Daily briefing on Pharma Industry News
Get Started